4-168928326-TAAAA-TAAAAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The ENST00000507699.1(PALLD):n.3748dupA variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.070 ( 577 hom., cov: 0)
Exomes 𝑓: 0.042 ( 12 hom. )
Consequence
PALLD
ENST00000507699.1 non_coding_transcript_exon
ENST00000507699.1 non_coding_transcript_exon
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.04
Publications
1 publications found
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.154 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0698 AC: 10563AN: 151314Hom.: 576 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
10563
AN:
151314
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0423 AC: 1183AN: 27994Hom.: 12 Cov.: 0 AF XY: 0.0416 AC XY: 535AN XY: 12850 show subpopulations
GnomAD4 exome
AF:
AC:
1183
AN:
27994
Hom.:
Cov.:
0
AF XY:
AC XY:
535
AN XY:
12850
show subpopulations
African (AFR)
AF:
AC:
127
AN:
958
American (AMR)
AF:
AC:
25
AN:
610
Ashkenazi Jewish (ASJ)
AF:
AC:
121
AN:
1766
East Asian (EAS)
AF:
AC:
6
AN:
5512
South Asian (SAS)
AF:
AC:
0
AN:
228
European-Finnish (FIN)
AF:
AC:
4
AN:
442
Middle Eastern (MID)
AF:
AC:
16
AN:
172
European-Non Finnish (NFE)
AF:
AC:
735
AN:
16012
Other (OTH)
AF:
AC:
149
AN:
2294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0699 AC: 10580AN: 151428Hom.: 577 Cov.: 0 AF XY: 0.0658 AC XY: 4871AN XY: 73996 show subpopulations
GnomAD4 genome
AF:
AC:
10580
AN:
151428
Hom.:
Cov.:
0
AF XY:
AC XY:
4871
AN XY:
73996
show subpopulations
African (AFR)
AF:
AC:
6465
AN:
41072
American (AMR)
AF:
AC:
787
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
AC:
254
AN:
3470
East Asian (EAS)
AF:
AC:
7
AN:
5150
South Asian (SAS)
AF:
AC:
45
AN:
4812
European-Finnish (FIN)
AF:
AC:
93
AN:
10476
Middle Eastern (MID)
AF:
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2709
AN:
67912
Other (OTH)
AF:
AC:
144
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
456
912
1369
1825
2281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Carcinoma of pancreas Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.